[PMID: 8082983] PubMed record related to this compound for laboratory literature review
Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
Homocysteine levels tend to be higher in people who dont have adequate folate and B12 intakes
You have atrophic gastritis, an inflammation of the stomach lining
What to Expect: Consultation + treatment: ~30 minutes Downtime: None Results: Feel energized, refreshed, and more focused **Results vary from client-to-client**
Amber vials or foil-wrapped storage reduces UV exposure during handling and transit